Environmental Impact of Animal Experimentation

#

Introduction

#

Animal experimentation has long been a cornerstone of biomedical research, yet its environmental impacts remain under-discussed. As global awareness of sustainability grows, the scientific community faces increasing pressure to evaluate and mitigate the ecological consequences of animal testing. This report provides a multidimensional analysis of how animal experimentation affects the environment, encompassing resource consumption, pollution, ecological disruption, carbon footprint, and long-term environmental consequences.

The Progressive Non-Animal Research Society (PNARS) commissioned its own report, the Environmental Impacts Of Animal Experimentation (2023) to assess environmental hazards associated with animal experimentation, particularly in the context of the new St. Paul’s Hospital and Health Campus in Vancouver, British Columbia¹. This report by Amelia Porter (linkedin profile) synthesizes findings from scientific literature, regulatory documents, and environmental assessments to provide a comprehensive overview (and is the most cited reference for this page).

Global and Canadian Animal Usage

#

Worldwide, a conservative estimate places the number of animals used in experimentation at nearly 200 million annually¹. In Canada, the Canadian Council on Animal Care (CCAC) reported 3,692,479 animals used in 2021 by certified institutions, with mice (34.1%), fish (33.1%), and birds (12%) being the most commonly used species^{1 2}. These numbers do not include animals used in non-CCAC certified facilities, suggesting the actual figure is significantly higher¹. From 2005 to 2015, Canada moved from the sixth to the fourth largest user of animals in research globally, with notable increases in the use of dogs and non-human primates¹.

The following table summarizes the reported animal usage from 2021-2024:

Year	Total Animals	Species 1	Species 2	Species 3
2024	3,706,907	Fish (1,713,418 - 46.2%)	Mice (1,202,233 - 32.4%)	Cattle (369,769 - 10.0%)
2023	3,128,943	Mice (1,150,348 - 36.8%)	Fish (1,007,102 - 32.2%)	Cattle (547,970 - 17.5%)
2022	3,521,143	Mice (1,340,916 - 38.1%)	Fish (1,198,299 - 34.0%)	Cattle (462,025 - 13.1%)
2021	3,692,479	Mice (1,259,196 - 34.1%)	Fish (1,251,563 - 33.9%)	Birds (444,596 - 12.0%)

Despite the growing adoption of alternative methods, such as in vitro and in silico technologies, gross animal use has not declined proportionally. This is due, in part, to increased regulatory testing demands and a rise in basic biological research, particularly involving genetically modified animals¹.

Resource Consumption

#

Energy

#

Animal research facilities consume up to ten times more energy per square meter than standard office buildings^{1 3}. This elevated demand is primarily due to:

• The need for 20 or more air exchanges per hour for ventilation, far exceeding standard laboratory requirements^{1 3}.
• Environmental controls for animal housing, including temperature, humidity, and lighting.
• Power-intensive equipment such as anesthesia systems, surgical platforms, and waste disposal units¹.

The energy requirements for maintaining these conditions contribute significantly to the carbon footprint of animal research facilities.

Water

#

Laboratories consume substantial volumes of water for:

• Animal care, including hydration systems and sanitation.
• Experimental procedures and waste disposal.
• Cleaning and sterilization of equipment and facilities⁴.

In regions with water scarcity, this demand places additional strain on local resources.

Chemicals and Drugs

#

Animal research relies heavily on a wide array of chemicals, including:

• Sanitization and disinfection agents (eg bleach, formaldehyde).
• Research chemicals such as irritants, corrosive substances, neurotoxins, reproductive toxins, and carcinogens (eg benzene, arsenic, DDT, chloroform)¹.
• Pharmaceuticals, including antibiotics, endocrine disruptors, and cytotoxic drugs¹.

These substances are often used in larger quantities and for longer durations than in non-animal research, increasing the risk of environmental contamination¹.

Plastics and Consumables

#

Animal research laboratories require an extensive assortment of single-use plastics and consumables, including:

• Personal protective equipment (PPE) such as gloves, masks, and disposable garments.
• Animal care supplies (eg cages, bedding, hydration systems, feed).
• Surgical and experimental supplies (eg syringes, needles, catheters, tubing)¹.

The disposal of these materials contributes to the plastic waste crisis and increases the volume of biomedical waste requiring incineration or specialized disposal¹.

Environmental Pollution

#

Wastes Generated

#

Animal experimentation produces significant quantities of both non-hazardous and hazardous waste, including:

• Animal carcasses: Millions of animal bodies are rendered as hazardous waste annually¹.
• Biological waste: Excrement, bedding, excess feed, and caging contaminated with toxins, chemicals, drugs, or pathogens¹.
• Sharps and laboratory waste: Needles, syringes, scalpel blades, and other contaminated materials¹.
• Chemical waste: Solvents, reagents, and other hazardous chemicals used in experiments¹.

Incineration and Its Impacts

#

Incineration is the preferred disposal method for hazardous biomedical waste, including animal carcasses and contaminated materials¹. However, this process generates significant environmental pollution:

• Air emissions: Incinerators release particulate matter, nitrogen dioxide (NO₂), sulfur dioxide (SO₂), carbon monoxide (CO), and volatile organic compounds (VOCs)^{1 3}. Animal waste incinerators, in particular, emit higher concentrations of toxic contaminants, including heavy metals (eg mercury, lead) and polycyclic aromatic hydrocarbons (PAHs), which are persistent and carcinogenic^{1 3}.
• Dioxins and furans: These highly toxic compounds are produced during the incineration of chlorine-containing materials and are known to cause cancer, reproductive disorders, and immune system damage^{1 5}.
• Greenhouse gases: Incineration contributes to CO₂ emissions, further exacerbating climate change¹.

Incineration also requires high fuel consumption to maintain the necessary temperatures, and the resulting ash often contains toxic residues that must be disposed of in specialized landfills^{1 3}.

Water Pollution

#

Animal research contributes to water pollution through:

• Sewer discharge: Hospitals and research facilities release untreated or partially treated wastewater containing drugs, hormones, antibiotics, and cytotoxic chemicals into municipal sewer systems¹. Many of these substances cannot be effectively removed by standard wastewater treatment processes¹.
• Runoff from incineration facilities: Toxic ash and residues can leach into groundwater, contaminating local water supplies¹.

The presence of antibiotics, endocrine disruptors, and cytotoxic drugs in waterways poses risks to aquatic ecosystems and may contribute to antimicrobial resistance and other long-term environmental effects¹.

Soil Contamination

#

Toxic substances from incineration and chemical runoff can accumulate in soil, leading to:

• Bioaccumulation of heavy metals and persistent organic pollutants in plants and animals¹.
• Disruption of soil microbiomes, affecting nutrient cycling and ecosystem health⁶.

Human Health Implications

#

Occupational Health Risks

#

Laboratory workers involved in animal research face significant occupational health risks, including:

• Allergic reactions: Exposure to animal allergens (eg dander, urine, saliva) can cause laboratory animal allergy (LAA), with prevalence rates ranging from 11% to 44% among exposed workers⁷.
• Asthma: Up to 22% of laboratory animal workers develop occupational asthma due to sensitization to animal allergens⁷.
• Zoonotic diseases: Animal laboratories are a known source of zoonoses—diseases transmitted from animals to humans. Pathogens such as Salmonella, Brucella, and Hantavirus pose risks to workers, and there is growing concern about the potential for laboratory-acquired infections (LAIs)^{1 8}.
• Chemical exposure: Workers may be exposed to toxic chemicals, anesthetic gases, and radiation, leading to acute and chronic health effects¹.

The COVID-19 pandemic has highlighted the risks of laboratory-acquired infections. Research suggests that viral serial passage—a common laboratory procedure involving live animal hosts—may have played a role in the emergence of SARS-CoV-2^{1 9}. The Center for Arms Control and Non-Proliferation estimates the odds of a potential pandemic pathogen leaking from a lab at one in four^{1 10}.

Public Health Risks

#

Communities near incineration facilities are exposed to toxic emissions through:

• Inhalation of particulate matter, dioxins, and heavy metals^{1 5}.
• Ingestion of contaminated food and water¹.
• Dermal contact with contaminated soil or water¹.

Exposure to these pollutants is associated with:

• Respiratory diseases (eg asthma, bronchitis).
• Cardiovascular diseases (eg heart attacks, strokes).
• Cancer (linked to dioxins, PAHs, and heavy metals).
• Reduced life expectancy and increased mortality rates^{1 5}.

Some pollutants, such as dioxins and mercury, are persistent and can be transported long distances, affecting distant communities^{1 5}.

Ecological Disruption and Biodiversity Loss

#

Animal experimentation contributes to ecological disruption through:

• Release of toxic substances into air, water, and soil, which can harm non-target species and ecosystems¹.
• Genetic pollution: The escape or release of genetically modified animals or organisms into the wild can disrupt local ecosystems and outcompete native species¹.
• Habitat destruction: The production of animal feed (eg soy, corn) for research animals contributes to deforestation and habitat loss, particularly in regions such as the Amazon¹¹.

The loss of biodiversity weakens ecosystem resilience and reduces the ability of natural systems to adapt to environmental changes⁶.

Carbon Footprint and Climate Change

#

Animal experimentation contributes to climate change through:

• Energy consumption: The high energy demands of animal research facilities result in significant CO₂ emissions^{1 3}.
• Incineration: The combustion of animal waste and contaminated materials releases CO₂, methane (CH₄), and nitrous oxide (N₂O), all potent greenhouse gases¹.
• Transportation: The movement of animals, equipment, and waste between facilities contributes to fossil fuel consumption and emissions¹.

Climate change, in turn, exacerbates environmental and public health challenges, including:

• Increased frequency of extreme weather events.
• Spread of infectious diseases (eg vector-borne illnesses).
• Disruption of ecosystems and loss of biodiversity^{12 13}.

The climate crisis is a human health emergency, as noted by Canada’s Chief Public Health Officer, Dr. Theresa Tam¹.

Long-Term Environmental Consequences

#

The long-term environmental consequences of animal experimentation include:

• Persistent pollution: Toxic substances such as dioxins, heavy metals, and PAHs can remain in the environment for decades, accumulating in ecosystems and posing ongoing risks to human and ecological health^{1 5}.
• Antimicrobial resistance: The overuse of antibiotics in animal research contributes to the global crisis of antimicrobial resistance, which threatens to render many infections untreatable¹⁴.
• Loss of ecosystem services: Biodiversity loss and ecological disruption reduce the ability of ecosystems to provide clean air, water, and soil, as well as pollination and climate regulation⁶.

These consequences underscore the need for sustainable research practices that minimize environmental harm.

Regulatory Framework and Ethical Considerations

#

Current Regulations

#

In Canada, oversight of animal experimentation is primarily conducted by the Canadian Council on Animal Care (CCAC), which provides guidelines for the ethical use of animals in research². However, the CCAC operates on a voluntary basis, and its standards are not legally enforceable^{1 15}. This lack of regulatory power has led to concerns about transparency and accountability in animal research^{1 15}.

Key issues with the current system include:

• Incomplete data: Animal use statistics are based on voluntary reporting from CCAC-certified institutions, excluding private companies and non-certified facilities^{1 2}.
• Lack of trend analysis: The CCAC does not publish long-term trends in animal use, making it difficult to assess progress toward the Three R principles (Replacement, Reduction, Refinement)^{1 15}.
• No environmental oversight: Current regulations focus on animal welfare but do not address the environmental impacts of animal research¹.

Ethical Considerations

#

The Three R principles—Replacement, Reduction, and Refinement—are widely recognized as a framework for ethical animal research. However, their implementation has been inconsistent. Key ethical concerns include:

• Scientific validity: Growing evidence suggests that animal models often fail to predict human outcomes, leading to misleading results and wasted resources^{1 16}.
• Public accountability: There is a lack of transparency in reporting animal use numbers, experimental procedures, and environmental impacts¹.
• Alternatives bias: Some scientific journals exhibit animal-reliance bias, requesting animal data to validate non-animal studies, which hinders the adoption of innovative methods^{1 17}.

Progress in Regulation

#

Recent regulatory changes offer hope for reducing animal testing:

• Canada: In 2023, amendments to the Canadian Environmental Protection Act (CEPA) and the Food and Drug Act banned cosmetic testing on animals and committed to phasing out toxicity testing by 2035¹.
• United States: The FDA Modernization Act (2022) allows the use of non-animal testing methods (eg cell-based assays, organ-on-a-chip models) for drug approvals, reducing reliance on animal tests¹⁸.
• European Union: The 2010 EU Directive aims to phase out animal experiments, and the 2021 European Parliament resolution calls for accelerated transition to innovation without animals¹.

These developments signal a global shift toward reducing and eventually eliminating animal testing in favor of more human-relevant and sustainable methods.

Alternative Methods to Animal Testing

#

In Silico Modeling

#

In silico methods use computational models to simulate biological processes, drug responses, and toxicity. These approaches include:

• Quantitative Structure-Activity Relationship (QSAR) models: Predict the biological activity of chemicals based on their molecular structure¹⁹.
• Virtual control groups (VCGs): Use historical animal data to create predictive models, reducing the need for new animal tests while maintaining regulatory compliance²⁰.

In Vitro Methods

#

In vitro (cell-based) methods provide human-relevant alternatives to animal testing:

• Organ-on-a-chip technology: Microfluidic devices that mimic the structure and function of human organs, allowing for more accurate drug testing and disease modeling^{1 21}.
• 3D cell cultures: Human cells grown in three-dimensional scaffolds to better replicate tissue architecture and function²¹.
• Human stem cells: Induced pluripotent stem cells (iPSCs) can be differentiated into various cell types for testing²¹.

Economic and Scientific Benefits

#

Transitioning to non-animal methods offers significant advantages:

• Cost savings: In vitro and in silico methods can reduce R&D costs by 10% to 26%²².
• Faster results: Non-animal methods can accelerate drug discovery and approval, reducing the time to market²².
• Improved accuracy: Human-based models provide more predictive results for human health outcomes, reducing the risk of failed clinical trials^{1 22}.
• Environmental benefits: Non-animal methods reduce resource consumption, waste generation, and pollution²².

Case Study: St. Paul’s Hospital and Providence Health Care

#

Current Practices

#

St. Paul’s Hospital (SPH), operated by Providence Health Care (PHC), is a major research facility in Vancouver, British Columbia. Animal experimentation is conducted at SPH, including research involving rodents, rabbits, sheep, pigs, and dogs¹. The Heart and Lung Institute at SPH offers pre-clinical animal testing services for contract research, including studies on cardiovascular disease, COPD, and muscular dystrophy¹.

Despite PHC’s commitments to environmental sustainability, there is a lack of transparency regarding animal use and its environmental impacts. Key findings include:

• No public reporting of animal use numbers, species, or experimental procedures¹.
• No mention of animal experimentation in sustainability plans or environmental impact assessments¹.
• No alignment with the Three R principles in public documentation¹.

Environmental Hazards at SPH

#

The environmental hazards associated with animal research at SPH include:

• Resource consumption: High energy and water use for animal facilities^{1 3}.
• Waste generation: Production of biohazardous and biomedical waste, including animal carcasses, bedding, and contaminated materials¹.
• Incineration: Animal waste from SPH is likely transported to off-site facilities for incineration, contributing to air pollution and greenhouse gas emissions¹. For example, affiliated institutions such as UBC transport pathological waste to Mission, BC, and biomedical waste to Alberta for incineration¹.
• Sewer discharge: SPH is subject to the Hospital Pollution Prevention Bylaw (Bylaw No. 319), which requires hospitals to develop pollution prevention plans to reduce the discharge of biomedical waste, unused drugs, formaldehyde, and silver-rich solutions into sewer systems¹.

Opportunities for Change

#

The construction of the New St. Paul’s Hospital and Health Campus (NSPH) presents a unique opportunity to transition away from animal experimentation. Key recommendations for PHC and SPH include:

1. Adopt non-animal methods: Invest in organ-on-a-chip technology, in vitro models, and computational methods to replace animal testing¹.
2. Improve transparency: Publicly report animal use numbers, species, and experimental procedures, as well as efforts to achieve the Three R principles¹.
3. Align with sustainability goals: Incorporate the environmental impacts of animal research into sustainability planning and reporting¹.
4. Establish an alternatives center: Create a center for human-relevant innovation at NSPH, similar to the Canadian Centre for Alternatives to Animal Methods (CCAAM) at the University of Windsor¹.
5. Address questionable research practices: Implement registered reports and comprehensive reporting guidelines to improve the rigor and reproducibility of animal research¹.

Recommendations

#

For Healthcare Institutions and Research Facilities

#

1. Phase out animal experimentation: Transition to non-animal methods (eg organ-on-a-chip, in vitro models, in silico modeling) to reduce environmental and ethical concerns^{1 22}.
2. Improve transparency: Publicly report animal use data, including numbers, species, and experimental procedures, as well as efforts to achieve the Three R principles¹.
3. Adopt sustainable practices: Reduce energy and water consumption, improve waste management, and minimize the use of toxic chemicals in research^{1 3}.
4. Invest in innovation: Allocate funding for alternative methods and establish centers for human-relevant research¹.
5. Collaborate with regulators: Work with government agencies to update regulatory frameworks and promote the adoption of non-animal testing methods¹.

For Governments and Regulatory Bodies

#

1. Strengthen regulations: Enforce mandatory reporting of animal use and environmental impacts, and phase out animal testing in favor of non-animal methods^{1 15}.
2. Fund alternative methods: Provide grants and incentives for the development and adoption of non-animal testing technologies^{1 22}.
3. Update drug approval processes: Follow the example of the FDA Modernization Act and allow non-animal methods for drug safety and efficacy testing¹⁸.
4. Ban animal testing in cosmetics and toxicity testing: Expand bans on animal testing to include all categories of research, not just cosmetics¹.

For Scientific Journals and Publishers

#

1. Eliminate animal-reliance bias: Stop requiring animal data to validate non-animal studies, and promote the Three R principles in peer review^{1 17}.
2. Encourage registered reports: Adopt preregistration for animal studies to improve transparency and reproducibility¹.
3. Promote open access: Make animal use data and environmental impact assessments publicly available¹.

For the Public and Advocacy Groups

#

1. Raise awareness: Educate the public about the environmental and ethical impacts of animal experimentation¹.
2. Advocate for change: Support legislation and policies that reduce or eliminate animal testing¹.
3. Promote alternatives: Encourage the adoption of non-animal methods in research and education²².

Conclusion

#

Animal experimentation exerts a substantial and multifaceted environmental impact, encompassing pollution, resource consumption, ecological disruption, and contributions to climate change. While animal research has historically advanced medical science, its environmental costs and ethical concerns necessitate a critical reevaluation.

The transition to non-animal research methods, supported by innovations such as in silico modeling, in vitro technologies, and organ-on-a-chip systems, offers significant economic, scientific, and environmental benefits. These alternatives reduce resource consumption, pollution, and carbon footprint while improving the predictive accuracy and safety of drug development.

Stakeholders—including healthcare institutions, governments, scientific journals, and the public—must collaborate to implement stronger regulations, fund sustainable research, and promote interdisciplinary innovation. The future of biomedical research lies in balancing scientific progress with environmental stewardship, ensuring that life-saving advancements do not come at the expense of ecological health and human well-being.

As noted by Dr. Theresa Tam, Canada’s Chief Public Health Officer:

“Climate action is public health action. Let’s boldly act together and act now.”¹

References

#